Company intelligence / Profile preview

Genalyte

San Diego, California, United States

Ownership: Private
Employees: ~113
Development stage: Other

Overview

Genalyte commercializes the Merlin system, an on-site blood testing device intended for rapid, multiplexed diagnostics at the point of care, capable of delivering physician-verified laboratory test results from whole blood samples in under 30 minutes. The company notably received FDA Emergency Use Authorization for a COVID-19 antibody panel, and its platform is used in physician offices, urgent care centers, and other care settings. The Merlin system is actively deployed and used with expanding menu offerings.

Therapeutic areas: NephrologyHematologyInfectious DiseasesMetabolic Disorders
Modalities: DeviceDiagnostic platform
Industry: Protein Biomarker Diagnostics

Partnerships

Burjeel Holdings (strategic partnership in UAE)

Beyond the preview

Go deeper on Genalyte.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genalyte.

Explore the full profile